Cargando…

Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction

Background. The relevance of antibodies (Abs) in the defense against Mycobacterium tuberculosis infection remains uncertain. We investigated the role of Abs to the mycobacterial capsular polysaccharide arabinomannan (AM) and its oligosaccharide (OS) fragments in humans. Methods. Sera obtained from 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Tingting, Blanc, Caroline, Eder, Anke Z., Prados-Rosales, Rafael, Souza, Ana Camila Oliveira, Kim, Ryung S., Glatman-Freedman, Aharona, Joe, Maju, Bai, Yu, Lowary, Todd L., Tanner, Rachel, Brennan, Michael J., Fletcher, Helen A., McShane, Helen, Casadevall, Arturo, Achkar, Jacqueline M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918826/ https://www.ncbi.nlm.nih.gov/pubmed/27056953 http://dx.doi.org/10.1093/infdis/jiw141

Ejemplares similares

Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine
por: Prados-Rosales, Rafael, et al.
Publicado: (2017)

Monoclonal antibodies from humans with Mycobacterium tuberculosis exposure or latent infection recognize distinct arabinomannan epitopes
por: Ishida, Elise, et al.
Publicado: (2021)

The mycobacterial glycoside hydrolase LamH enables capsular arabinomannan release and stimulates growth
por: Franklin, Aaron, et al.
Publicado: (2023)

Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan
por: Liu, Yanyan, et al.
Publicado: (2023)

Gene Expression and Cytokine Profile Correlate With Mycobacterial Growth in a Human BCG Challenge Model
por: Matsumiya, Magali, et al.
Publicado: (2015)

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010–2014
por: Brennan, Michael J., et al.
Publicado: (2017)

Automated glycan assembly of arabinomannan oligosaccharides from Mycobacterium tuberculosis
por: Pardo-Vargas, Alonso, et al.
Publicado: (2019)

Role of Opsonophagocytosis in Immune Protection against Malaria
por: Leitner, Wolfgang W., et al.
Publicado: (2020)

Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
por: Naranbhai, Vivek, et al.
Publicado: (2015)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
por: Tanner, Rachel, et al.
Publicado: (2020)

Immune Adherence–mediated Opsonophagocytosis: The Mechanism of Leishmania Infection
por: Domínguez, Mercedes, et al.
Publicado: (1999)

Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination
por: Harris, Stephanie A., et al.
Publicado: (2014)

The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data
por: Glatman-Freedman, Aharona, et al.
Publicado: (2021)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
por: Pepponi, Ilaria, et al.
Publicado: (2017)

Twenty Years of Mycobacterial Glycans: Furanosides and Beyond
por: Lowary, Todd L.
Publicado: (2016)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis
por: Zelmer, Andrea, et al.
Publicado: (2016)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
por: McNeill, Eileen, et al.
Publicado: (2018)

Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021
por: Glatman-Freedman, Aharona, et al.
Publicado: (2021)

Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel
por: Glatman-Freedman, Aharona, et al.
Publicado: (2023)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
por: Tanner, Rachel, et al.
Publicado: (2017)

Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease
por: Dedrick, Rebekah M, et al.
Publicado: (2022)

Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures, Ashdod, Israel, 2021
por: Weinberger Opek, Moran, et al.
Publicado: (2021)

Effects of infection and disease with Mycobacterium tuberculosis on serum antibody to glucan and arabinomannan: two surface polysaccharides of this pathogen
por: Keitel, Wendy A, et al.
Publicado: (2013)

Expedient synthesis of the heneicosasaccharyl mannose capped arabinomannan of the Mycobacterium tuberculosis cellular envelope by glycosyl carbonate donors
por: Islam, Maidul, et al.
Publicado: (2017)

Combination of immune check inhibitor and immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: A case report
por: Kobayashi, Kunihiko, et al.
Publicado: (2021)

Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
por: Tanner, Rachel, et al.
Publicado: (2019)

Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT Proteins
por: Drori, Yaron, et al.
Publicado: (2020)

Under-diagnosis of SARS-CoV-2 infections among children aged 0–15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021
por: Indenbaum, Victoria, et al.
Publicado: (2021)

Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel
por: Glatman-Freedman, Aharona, et al.
Publicado: (2022)

Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy
por: Naranbhai, Vivek, et al.
Publicado: (2014)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
por: O’Shea, Matthew K., et al.
Publicado: (2018)

Factors associated with childhood influenza vaccination in Israel: a cross-sectional evaluation
por: Glatman-Freedman, Aharona, et al.
Publicado: (2019)

Mycobacterial Membrane Vesicles Administered Systemically in Mice Induce a Protective Immune Response to Surface Compartments of Mycobacterium tuberculosis
por: Prados-Rosales, Rafael, et al.
Publicado: (2014)

Characteristics of Nontuberculous Mycobacterial Infections at a Midwestern Tertiary Hospital: A Retrospective Study of 365 Patients
por: Hannah, Claire E, et al.
Publicado: (2020)

Aspirin enhances opsonophagocytosis and is associated to a lower risk for Klebsiella pneumoniae invasive syndrome
por: Lee, Chen-Hsiang, et al.
Publicado: (2014)

Alternative Complement Pathway Inhibition Abrogates Pneumococcal Opsonophagocytosis in Vaccine-Naïve, but Not in Vaccinated Individuals
por: Muri, Lukas, et al.
Publicado: (2021)

Clinical Implications of Size of Cavities in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Single-Center Cohort Study
por: Kang, Hye-Rin, et al.
Publicado: (2021)

Changing Incidence and Characteristics of Nontuberculous Mycobacterial Infections in Scotland and Comparison With Mycobacterium tuberculosis Complex Incidence (2011 to 2019)
por: Jarchow-MacDonald, Anna, et al.
Publicado: (2022)

Biosynthesis of mycobacterial arabinogalactan: identification of a novel α(1→3) arabinofuranosyltransferase
por: Birch, Helen L, et al.
Publicado: (2008)

Development of A Standardized Opsonophagocytosis Killing Assay for Group B Streptococcus and Assessment in an Interlaboratory Study
por: Leung, Stephanie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r6pbt6t47eq6cuchimbkjkag3m